Immunology and growth characteristics of ocular basal cell carcinoma

被引:6
|
作者
Rohrbach, JM
Stiemer, R
Mayer, A
Riedinger, C
Duijvestijn, A
Zierhut, M
机构
[1] Univ Kiel, Eye Clin, D-24105 Kiel, Germany
[2] Univ Tubingen, Eye Clin, Dept Gen Ophthalmol 1, Tubingen, Germany
[3] Univ Limburg, Dept Immunol, NL-6200 MD Maastricht, Netherlands
关键词
D O I
10.1007/s004170000221
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Knowledge about immunological features and growth characteristics of palpebral (ocular) basal cell carcinomas (BCCs) is limited. In particular, it is unclear whether ocular BCC represents in this regard a special BCC entity or not. Methods: Twenty BCCs of the lid area (ocular BCCs) were investigated immunohistologically using monoclonal antibodies against CD4, CDs, CD45Ro, CD50, CD68, HECA-452, Ki67 (MIB1), and the p53 epitope. For comparison, nine BCCs excised distant from the eye (non-ocular BCCs) were evaluated. Results: In BCCs the distribution of the immunocompetent cells investigated is markedly irregular. These cells are localized mainly around BCC islands. Only a few of them invade tumour cell aggregates. The CD4:CD8 ratio as detected by immunohistochemistry is >1 in 82% of ocular BCCs and in 88% of nonocular BCCs. Often there are dense infiltrations of CD68+ cells (macrophages) and HECA-452+ cells adjacent to tumour cell aggregates. The growth fraction [percentage of proliferating (Ki67+/MIB1+) cells] varies from 0% to more than 30%. Proliferative activity is enhanced at the invasion front. Additionally, the amount of p53+ cells differs considerably among the BCCs. Conclusions: CD4+ T cells seem to be the most important cell population for BCC immunosurveillance, offering the chance for conservative interferon therapy. The role of CD68+ and HECA-452+ cells has to be further elucidated. In many tumours the large amount of proliferating cells contrasts to the usually slow growth of BCCs, indicating strong apoptotic processes. The results can be regarded only as semiquantitative. So far, ocular and nonocular BCCs exhibit no essential differences regarding immunocompetent cell infiltration and growth characteristics. According to this, palpebral BCCs are "normal" BCCs and not a special BCC variant. Therefore, results from dermatological research concerning BCC can be extended without limitations to their counterparts in the lid area.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 50 条
  • [41] BASAL-CELL CARCINOMA AND LIFE-STYLE CHARACTERISTICS
    SAHL, WJ
    GLORE, S
    GARRISON, P
    OAKLEAF, K
    JOHNSON, SD
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1995, 34 (06) : 398 - 402
  • [42] Key characteristics of basal cell carcinoma with large subclinical extension
    Greywal, T.
    Goldenberg, A.
    Eimpunth, S.
    Jiang, S. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (03) : 485 - 490
  • [43] Metastasis of basal cell carcinoma in a patient with basal cell carcinoma syndrome
    Stewart, Nicholas C.
    O'Brien, Blake
    Francis, Leo
    Graham, David
    Yang, Steven
    PATHOLOGY, 2013, 45 (02) : 200 - 202
  • [44] Superficial basal cell carcinoma versus nodular basal cell carcinoma
    Delaunay, J.
    Moulin, C.
    Dalle, S.
    Thomas, L.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2014, 141 (04): : 312 - 313
  • [45] Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients
    Kricker, Anne
    Armstrong, Bruce
    Hansen, Vibeke
    Watson, Alan
    Singh-Khaira, Gurpreet
    Lecathelinais, Christophe
    Goumas, Chris
    Girgis, Afaf
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (03) : 456 - 464
  • [47] KERATINOCYTE GROWTH-FACTOR IN BASAL-CELL CARCINOMA
    HATA, TR
    UCHIYAMA, CM
    MIRELL, CJ
    TONG, A
    WU, V
    BARSKY, SH
    MOY, RL
    CLINICAL RESEARCH, 1991, 39 (01): : A140 - A140
  • [48] Epidermal growth factor receptor signalling in basal cell carcinoma
    Herath, D.
    Rahman, M.
    Mancuso, M.
    Panagou, L.
    Atkar, R.
    Pirzado, M.
    Saran, A.
    Harwood, C.
    Philpott, M.
    Neill, G.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (04) : e24 - e24
  • [49] Ocular Immunology
    S Louis Bridges
    Arthritis Research & Therapy, 2 (1)
  • [50] Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma
    Sagiv, Oded
    Nagarajan, Priyadharsini
    Ferrarotto, Renata
    Kandl, Thomas J.
    Thakar, Sudip D.
    Glisson, Bonnie S.
    Altan, Mehmet
    Esmaeli, Bita
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2019, 103 (06) : 775 - 780